Colorectal Cancer

Featured Article
Increased use of fecal immunochemical tests pandemic could mitigate concerns about lower rates of colonoscopy during the COVID-19, research indicates.
A photoacoustic microscopy and ultrasound system paired with a deep learning model showed high diagnostic performance and potential for optimizing post-treatment among patients who have completed radiation and chemotherapy for rectal cancer, new research shows.
Research reveals possible association of colorectal cancers and genetic predictions in circulating micronutrients in some populations.
Some patients are resistant to undergoing colonoscopy and fecal immunochemical testing for colon cancer screening. Do you offer alternative screening methodologies to your patients who refuse colonoscopy? Tell us with this quick poll!
New research reveals that both aspirin and selective serotonin reuptake inhibitors may reduce the risk of colorectal cancer--and together, these medications confer a greater protective effect.
Investigators sought to clarify whether adjuvant chemotherapy improves survival among patients with stage II colorectal cancer with and without high-risk characteristics.
Current guidelines call for a 10-year interval between colonoscopies to screen for colorectal cancer, but evidence that this screening reduces the risk of morbidity and mortality has been limited. Researchers looked at the long-term results in a new observational study.
In an award-winning poster presentation, researchers investigated whether using a polyp detection device aided by artificial intelligence could improve rates of detection of adenomas during colonoscopy.
Ulcerative colitis (UC) is associated with a higher risk of colorectal cancer (CRC), but national data on admissions of CRC among patients with UC are scarce. Authors of a study presented at the 2019 AIBD Meeting sought to better understand the incidence of CRC-related admissions in patients with UC in the United States.
Authors of a new study presented at the ACG 2019 Annual Meeting compared a single low-residue diet and a clear-liquid diet for bowel preparation quality, tolerance, and satisfaction among more than 150 patients scheduled for outpatient colonoscopy.
In this Q&A, Dr Steven Wexner from Cleveland Clinic Florida answers our burning questions relating to his session on a multidisciplinary approach to managing rectal cancer, which he presented at MISS 2018.